Firm Analyst
Maxim Group Jason McCarthy, Ph.D.
Zacks Small-Cap Research John D. Vandermosten, CFA

Lexaria Bioscience Corp. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Lexaria Bioscience Corp.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Lexaria Bioscience Corp. or its management. Lexaria Bioscience Corp. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.